Serum ferritin level is a prognostic marker in patients with peripheral T‐cell lymphoma
Satoshi Koyama(Yokohama City University), Hideaki Nakajima(National Institute of Advanced Industrial Science and Technology), Megumi Itabashi(Shizuoka Red Cross Hospital), Hirotaka Takasaki(Kanagawa Prefectural Hospital Organization), Hideyuki Koharazawa(Yokohama City University Medical Center), Shin Fujisawa(Yokohama City University Medical Center), Naoto Tomita(St. Marianna University School of Medicine), Sachiya Takemura(Osaka Ekisaikai Hospital), Daisuke Ishibashi(Fukuoka University), Rika Kawasaki(Yokohama City University Medical Center), Yoshimi Ishii(Yokohama City University Medical Center), Kenji Motohashi(Yokohama City University Medical Center), Yuki Nakajima(Fujisawa City Hospital), Rika Sakai(Yokohama City University Medical Center), S Motomura(Kanagawa Prefectural Hospital Organization), Etsuko Yamazaki(Yokohama City University), Chizuko Hashimoto(Yamato Municipal Hospital), R Watanabe(Juntendo University Shizuoka Hospital), Yukako Hattori(Kanagawa Prefectural Hospital Organization)
Cited by 35
Related Papers
AML1 mutations induced MDS and MDS/AML in a mouse BMT model
|Blood|2008|149
Monitoring of Hepatitis B Virus (HBV) DNA and Risk of HBV Reactivation in B-Cell Lymphoma: A Prospective Observational Study
|Clinical Infectious Diseases|2015|149
Dimerization of MLL fusion proteins and FLT3 activation synergize to induce multiple-lineage leukemogenesis
|Journal of Clinical Investigation|2005|112
Dimerization of MLL fusion proteins and FLT3 activation synergize to induce multiple-lineage leukemogenesis
|Journal of Clinical Investigation|2005|110
Characterization of a new SARS-CoV-2 variant that emerged in Brazil
|Proceedings of the National Academy of Sciences|2021|87